28 March, 2023 Sobi offers new thinner, latex-free needle for Kineret® (anakinra) 28 March, 2023 Study Shows RSV Hospitalizations Cause Caregivers Missed Work, Emotional Distress, Financial Concerns and Family Disruption 28 March, 2023 Video Alert: New Video Illustrates Mechanism of Action for Gamifant® (emapalumab-lzsg) 15 June, 2020 Sobi and Selecta announce strategic licensing agreement for SEL-212, a phase 3-ready novel treatment for Chronic Refractory Gout 7 May, 2020 Results from pivotal phase 2/3 study of emapalumab in patients with primary HLH published in New England Journal of Medicine 5 May, 2020 Sobi publishes report for the first quarter 2020 28 February, 2020 New research uncovers the toll rare diseases take on relationships 13 February, 2020 Sobi publishes report for the fourth quarter and full-year 2019 5 December, 2019 Data to be highlighted at the American Society of Hematology 2019 Annual Meeting 12 November, 2019 Sobi successfully completes acquisition of Dova Pharmaceuticals Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »